Do Artemisia annua L. compounds have SARS-CoV-2 antiviral potential?

Caused by SARS-CoV-2, the ongoing COVID-19 pandemic has led to over 121.2 million cases and over 2.6 million deaths worldwide. An interesting new study examines the potential antiviral activity of compounds present in the plant Artemisia annua L.

Researchers evaluate artemisinin for COVID-19 management

Robust Antiviral Activity of Santonica Flower Extract (Artemisia cina) against Avian and Human Influenza A Viruses: In Vitro and Chemoinformatic Studies

Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants

A Reappraisal of the Antiviral Properties of and Immune Regulation through Dietary Phytochemicals

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect

Nutrients, Free Full-Text

Artemisia annua L. hot-water extracts show potent activity in vitro against Covid-19 variants including delta - ScienceDirect

Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro

Antiviral Phytocompounds Against Animal-to-Human Transmittable SARS-CoV-2

IJMS, Free Full-Text

SARS-CoV-2 omicron variants are susceptible in vitro to Artemisia annua hot water extracts - ScienceDirect

IJMS, Free Full-Text

In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic? - ScienceDirect

Biologics, Free Full-Text